Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

1. Haude, M.
2. Ince, H.
3. Abizaid, A.
4. Toelg, R.
5. Lemos, P.A.
6. Von Birgelen, C.
7. Christiansen, E.Hø.
8. Wijns, W.
9. Neumann, F.-J.
10. Kaiser, C.
11. Eeckhout, E.
12. Lim, S.T.
13. Escaned, J.
14. Garcia-Garcia, H.M.
15. Waksman, R.